Impact of Reduced Vancomycin MIC on Clinical Outcomes of Methicillin-Resistant Staphylococcus aureus Bacteremia

Vancomycin has been a key antibiotic agent for the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections. However, little is known about the relationship between vancomycin MIC values at the higher end of the susceptibility range and clinical outcomes. The aim of this study was...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Park, So-Youn, Oh, In-Hwan, Lee, Hee-Joo, Ihm, Chun-Gyoo, Son, Jun Seong, Lee, Mi Suk, Kim, Mi-Na
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: American Society for Microbiology 2013
Onderwerpen:
Susceptibility
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3811271/
https://ncbi.nlm.nih.gov/pubmed/23979741
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01137-13
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items